Article Information
PubMed
Published By
History
- Received April 2, 2007
- Revision received May 3, 2007
- Accepted May 7, 2007
- First published June 20, 2007.
- Version of record published June 20, 2007.
Copyright & Usage
Copyright © 2007 Society for Neuroscience 0270-6474/07/276843-09$15.00/0
Author Information
- 1Howard Hughes Medical Institute, Department of Biological Sciences, Stanford University, Stanford, California 94305,
- 2Department of Cell and Neurobiology, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, and
- 3Division of Research, Genentech, South San Francisco, California 94080
- Correspondence should be addressed to Marc Tessier-Lavigne, Division of Research, Genentech, 1 DNA Way, South San Francisco, CA 94080. marctl{at}gene.com
Author contributions
Disclosures
- Received April 2, 2007.
- Revision received May 3, 2007.
- Accepted May 7, 2007.
-
This work was supported by Damon Runyon Cancer Research Foundation Grant DRG-#1607 (L.M.) and by the Howard Hughes Medical Institute (M.T.-L.). We thank A. Plump, H. Long, C. Sabatier, A. Yaron, F. Wang, and other members of the Tessier-Lavigne laboratory for helpful discussions and for sharing expertise and reagents, and we thank H. Lin for technical assistance. We thank Louis Reichardt for the TrkA antibody, David Ornitz for the Slit3 mouse, and Whit Tao and Mu-ming Poo for help with DiI iontophoresis. We also thank Tom Jessell for critical comments on this manuscript.
- Correspondence should be addressed to Marc Tessier-Lavigne, Division of Research, Genentech, 1 DNA Way, South San Francisco, CA 94080. marctl{at}gene.com